Multiple pH responsive zwitterionic micelles for stealth delivery of anticancer drugs. Issue 69 (8th July 2016)
- Record Type:
- Journal Article
- Title:
- Multiple pH responsive zwitterionic micelles for stealth delivery of anticancer drugs. Issue 69 (8th July 2016)
- Main Title:
- Multiple pH responsive zwitterionic micelles for stealth delivery of anticancer drugs
- Authors:
- Ma, Jin
Kang, Ke
Yi, Qiangying
Zhang, Zhirong
Gu, Zhongwei - Abstract:
- Abstract : Subtle tumor micro-environmental pH gradient activates functionalization of the zwitterionic micelles for stealth delivery and intelligent release of anti-cancer drug doxorubicin. Abstract : In this work, we reported zwitterion-functionalized "stealth" micelles for intelligent delivery of anticancer drugs. The amphiphilic polymer, poly(carboxybetaine methacrylate)- block -poly[2, 2-di(acryloyloxy-1-ethoxy)propane- co -4, 4-trimethylene dipiperidine [pCBMA- b -p(ADA-TMDP)], was synthesized via ATRP and subsequent Michael addition reaction. The assembled polymeric micelles were demonstrated as nanoscale (69 ± 20 nm) carriers possessing zwitterionic tentacles. Specifically, the hydrophilic zwitterionic tentacles, which were composed of the pCBMA component, could not only significantly resist protein adsorption to realize "stealth" transportation and prolong the circulation time of the drug delivery system in the blood stream, but also reverse its surface charge to facilitate cellular uptake in response to the extracellular pH environment (pH 6.8); the steady drug encapsulation cavities, as assemblies of p(ADA-TMDP) units, endowed the micelles intracellular environmental pH-responsive properties for potential endosomal escape and desired drug release after their accumulation in tumor sites through the EPR effect. The anticancer activity of these zwitterionic micelles carrying doxorubicin (DOX) was systematically studied here. At low pH ( e.g., pH 5.0), cleavage of theAbstract : Subtle tumor micro-environmental pH gradient activates functionalization of the zwitterionic micelles for stealth delivery and intelligent release of anti-cancer drug doxorubicin. Abstract : In this work, we reported zwitterion-functionalized "stealth" micelles for intelligent delivery of anticancer drugs. The amphiphilic polymer, poly(carboxybetaine methacrylate)- block -poly[2, 2-di(acryloyloxy-1-ethoxy)propane- co -4, 4-trimethylene dipiperidine [pCBMA- b -p(ADA-TMDP)], was synthesized via ATRP and subsequent Michael addition reaction. The assembled polymeric micelles were demonstrated as nanoscale (69 ± 20 nm) carriers possessing zwitterionic tentacles. Specifically, the hydrophilic zwitterionic tentacles, which were composed of the pCBMA component, could not only significantly resist protein adsorption to realize "stealth" transportation and prolong the circulation time of the drug delivery system in the blood stream, but also reverse its surface charge to facilitate cellular uptake in response to the extracellular pH environment (pH 6.8); the steady drug encapsulation cavities, as assemblies of p(ADA-TMDP) units, endowed the micelles intracellular environmental pH-responsive properties for potential endosomal escape and desired drug release after their accumulation in tumor sites through the EPR effect. The anticancer activity of these zwitterionic micelles carrying doxorubicin (DOX) was systematically studied here. At low pH ( e.g., pH 5.0), cleavage of the ketal bonds of the ADA segments and protonation of the TMDP segments both contributed to the swelling and disassembly of the zwitterionic micelles. Moreover, protonation of TMDP segments caused water influx and thus facilitated micelle endosomal escape. The drug release profiles revealed that these zwitterionic micelles could accelerate drug release remarkably more (3.26-fold) at pH 5 than pH 7.4, indicating the great potential to quickly release the vast majority of the drug in tumor tissue. Both in vitro and in vivo evaluations verified the high anticancer efficiency and greatly reduced side effects of DOX-loaded zwitterionic micelles as compared with the free drug DOX·HCl. … (more)
- Is Part Of:
- RSC advances. Volume 6:Issue 69(2016)
- Journal:
- RSC advances
- Issue:
- Volume 6:Issue 69(2016)
- Issue Display:
- Volume 6, Issue 69 (2016)
- Year:
- 2016
- Volume:
- 6
- Issue:
- 69
- Issue Sort Value:
- 2016-0006-0069-0000
- Page Start:
- 64778
- Page End:
- 64790
- Publication Date:
- 2016-07-08
- Subjects:
- Chemistry -- Periodicals
540.5 - Journal URLs:
- http://pubs.rsc.org/en/Journals/JournalIssues/RA ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/c6ra11645k ↗
- Languages:
- English
- ISSNs:
- 2046-2069
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8036.750300
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 1046.xml